Tandlægeselskabet Trustrup ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  5.1% 18.8% 19.6% 20.3% 18.2%  
Credit score (0-100)  45 8 7 5 7  
Credit rating  BBB B B B B  
Credit limit (kDKK)  0.0 0.0 -0.0 -0.0 -0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6

Net sales  0 0 0 0 0  
Gross profit  1,026 795 113 -65.5 -27.0  
EBITDA  421 -222 -444 -65.5 -27.0  
EBIT  210 -350 -444 -65.5 -27.0  
Pre-tax profit (PTP)  183.9 -350.2 -448.0 -68.2 -28.8  
Net earnings  138.4 -350.2 -448.0 -68.2 -28.8  
Pre-tax profit without non-rec. items  184 -350 -448 -68.2 -28.8  

 
See the entire income statement

Balance sheet (kDKK) 
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6

Tangible assets total  595 487 0.0 0.0 0.0  
Shareholders equity total  267 -83.6 -532 -600 -629  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,239 1,070 177 160 30.6  

Net Debt  -409 -378 -140 -145 -25.6  
 
See the entire balance sheet

Volume 
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,026 795 113 -65.5 -27.0  
Gross profit growth  56.6% -22.6% -85.8% 0.0% 58.7%  
Employees  0 3 2 0 0  
Employee growth %  0.0% 0.0% -33.3% -100.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  1,239 1,070 177 160 31  
Balance sheet change%  152.2% -13.7% -83.4% -9.5% -80.9%  
Added value  210.0 -350.2 -444.2 -65.5 -27.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  118 -256 -516 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  2.0 -1.0 -2.0 -3.0 -4.0  

Profitability 
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  20.5% -44.1% -393.9% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  24.8% -29.3% -47.7% -8.9% -3.8%  
ROI %  53.7% -262.7% -136.1% -10.0% -4.1%  
ROE %  70.1% -52.4% -71.9% -40.4% -30.2%  

Solidity 
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
Equity ratio %  21.5% -7.2% -75.0% -78.9% -95.4%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -97.1% 170.0% 31.5% 221.8% 94.7%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  13.7% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
Quick Ratio  0.6 0.5 3.2 1.5 5.3  
Current Ratio  0.6 0.5 3.2 1.5 5.3  
Cash and cash equivalent  408.9 377.8 140.1 145.2 25.6  

Capital use efficiency 
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -377.0 -599.2 121.0 53.7 24.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2017
2018/6
2018
2019/6
2019
2020/6
2020
2021/6
2021
2022/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 -117 -222 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 -74 -222 0 0  
EBIT / employee  0 -117 -222 0 0  
Net earnings / employee  0 -117 -224 0 0